down arrow

Lasa Supergeneri

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE670X01014
  • NSEID: LASA
  • BSEID: 540702
INR
18.09
0.29 (1.63%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 27.75 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

17.6318.35

52 Week

16.6533.49
Valuation
Technical
Day's Volume

CASH

27.75 k (-47.81%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

53.65%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -213.39% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.45
  • The company has been able to generate a Return on Equity (avg) of 3.57% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

Risky - Negative EBITDA

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 91 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.21

stock-summary
Return on Equity

-16.17%

stock-summary
Price to Book

0.98

Revenue and Profits (1 Year):
Net Sales:
33 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-31.86%
0%
-31.86%
1 Year
-30.15%
0%
-30.15%
2 Years
-22.23%
0%
-22.23%
3 Years
-71.01%
0.44%
-70.57%
4 Years
-72.84%
0.53%
-72.31%
5 Years
-48.24%
1.17%
-47.07%

Latest dividend: 0.20000000000000004 per share ex-dividend date: Sep-16-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.73%
EBIT Growth (5y)
-213.39%
EBIT to Interest (avg)
-1.45
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.04
Tax Ratio
19.20%
Dividend Payout Ratio
0
Pledged Shares
20.66%
Institutional Holding
0
ROCE (avg)
0.75%
ROE (avg)
3.57%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
0.98
EV to EBIT
-9.29
EV to EBITDA
-108.29
EV to Capital Employed
0.99
EV to Sales
0.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-10.27%
ROE (Latest)
-16.17%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

20.6612

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Omkar Pravin Herleker (53.65%)

Highest Public shareholder

Bnp Enterprises (8.48%)

Individual Investors Holdings

34.11%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 24.08% vs -15.90% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 476.03% vs 70.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.08",
          "val2": "26.66",
          "chgp": "24.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.79",
          "val2": "1.05",
          "chgp": "-24.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.47",
          "val2": "0.44",
          "chgp": "6.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.25",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.49",
          "val2": "-1.46",
          "chgp": "476.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.39%",
          "val2": "3.94%",
          "chgp": "-1.55%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 28.02% vs -12.28% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -19.92% vs 73.41% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "70.23",
          "val2": "54.86",
          "chgp": "28.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.58",
          "val2": "5.09",
          "chgp": "-49.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.11",
          "val2": "0.93",
          "chgp": "126.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-5.96",
          "val2": "-4.97",
          "chgp": "-19.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.67%",
          "val2": "9.28%",
          "chgp": "-5.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 26.73% vs -13.50% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 92.69% vs 72.77% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "103.31",
          "val2": "81.52",
          "chgp": "26.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.37",
          "val2": "6.14",
          "chgp": "-45.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.58",
          "val2": "1.37",
          "chgp": "88.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.25",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.47",
          "val2": "-6.43",
          "chgp": "92.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.26%",
          "val2": "7.53%",
          "chgp": "-4.27%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -19.47% vs -5.51% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 43.73% vs -619.18% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "104.34",
          "val2": "129.57",
          "chgp": "-19.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.17",
          "val2": "-6.59",
          "chgp": "132.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.93",
          "val2": "4.16",
          "chgp": "-53.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.77",
          "val2": "-19.90",
          "chgp": "55.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-21.73",
          "val2": "-38.62",
          "chgp": "43.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.08%",
          "val2": "-5.09%",
          "chgp": "7.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
33.08
26.66
24.08%
Operating Profit (PBDIT) excl Other Income
0.79
1.05
-24.76%
Interest
0.47
0.44
6.82%
Exceptional Items
8.25
0.00
Standalone Net Profit
5.49
-1.46
476.03%
Operating Profit Margin (Excl OI)
2.39%
3.94%
-1.55%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 24.08% vs -15.90% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 476.03% vs 70.33% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
70.23
54.86
28.02%
Operating Profit (PBDIT) excl Other Income
2.58
5.09
-49.31%
Interest
2.11
0.93
126.88%
Exceptional Items
0.00
0.00
Standalone Net Profit
-5.96
-4.97
-19.92%
Operating Profit Margin (Excl OI)
3.67%
9.28%
-5.61%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 28.02% vs -12.28% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -19.92% vs 73.41% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
103.31
81.52
26.73%
Operating Profit (PBDIT) excl Other Income
3.37
6.14
-45.11%
Interest
2.58
1.37
88.32%
Exceptional Items
8.25
0.00
Standalone Net Profit
-0.47
-6.43
92.69%
Operating Profit Margin (Excl OI)
3.26%
7.53%
-4.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 26.73% vs -13.50% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 92.69% vs 72.77% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
104.34
129.57
-19.47%
Operating Profit (PBDIT) excl Other Income
2.17
-6.59
132.93%
Interest
1.93
4.16
-53.61%
Exceptional Items
-8.77
-19.90
55.93%
Standalone Net Profit
-21.73
-38.62
43.73%
Operating Profit Margin (Excl OI)
2.08%
-5.09%
7.17%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -19.47% vs -5.51% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 43.73% vs -619.18% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Lasa Supergenerics Ltd stock-summary
stock-summary
Lasa Supergenerics Ltd
Micro Cap
Pharmaceuticals & Drugs
Lasa Supergenerics Limited was incorporated on March 11, 2016. The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
Company Coordinates stock-summary
Company Details
C-105 MIDC, Mahad Raigad Maharashtra : 402301
stock-summary
Tel: 91-2145-232101/232202
stock-summary
http://www.lasalabs.com
stock-summary
cs@lasalabs.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."